CDK2 and myelodysplastic syndrome: Sequence alignment of optimum amino-acids sequence predicted for TRAF6 with WT and mutant CDK2 (CDK2-122 and CDK2-123) (F–G) Myelodysplastic syndromes (MDS) patient derived samples (bone marrow/peripheral blood) were treated with DMSO or Dinaciclib (10 nM) or AT7519 (10 nM) for 14 days on methylcellulose clonogenic assays.